Symbiotec Pharmalab Fundamental Analysis
SYMBIOTEC
1075.5174.70 (-13.97%)
Last updated on 5 Sep, 2026 | 15:53 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Symbiotec Pharmalab Fundamentals
P/E Ratio
72.8
P/B Ratio
5.34
Div. Yield
0
Sector P/E
39.15
Sector P/B
3.25
Sec. Div. Yield
0.52
Symbiotec Pharmalab Fundamentals is currently trading with a P/E Ratio of 72.8, compared to the sector average of 39.15. Its P/B Ratio stands at 5.34, while the sector’s is 3.25. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.52%.
Symbiotec Pharmalab Score Card
Price
Attractive
Growth
Poor
Quality
Good
Management
Good
On its scorecard, Symbiotec Pharmalab reflects: Price – Attractive, Growth – Poor, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in SYMBIOTEC
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC